Cargando…
A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
The global pandemic of COVID-19 highlights the importance of vaccination, which remains the most efficient measure against many diseases. Despite the progress in vaccine design, concerns with suboptimal antigen immunogenicity and delivery efficiency prevail. Self-adjuvant carriers–vehicles that can...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110926/ https://www.ncbi.nlm.nih.gov/pubmed/35592309 http://dx.doi.org/10.3389/fchem.2022.864206 |